Accenture’s second-quarter fiscal 2026 earnings report shows strong growth, with revenues reaching $18 billion and earnings per share at $2.93, surpassing estimates.
The numbers
Accenture plc has announced its earnings for the second quarter of fiscal 2026, revealing a robust performance with earnings per share of $2.93, which exceeded the Zacks Consensus Estimate by 2.5%. The company reported total revenues of $18 billion, surpassing expectations by 1.2% and reflecting an impressive 8.3% increase compared to the same quarter last year.
Breaking down the revenue streams, Accenture’s managed services revenues reached $9.2 billion, marking a 10% increase from the previous year. Consulting revenues also demonstrated solid growth, climbing 7% year-over-year to $9 billion. However, the health and public service segment reported revenues of $3.7 billion, falling short of the consensus estimate of $3.8 billion.
In contrast, financial services revenues performed well, totaling $3.4 billion and exceeding the Zacks Consensus Estimate of $3.3 billion. This mixed performance across different segments highlights the varied demand for Accenture’s services in the current market landscape.
Accenture’s bookings for the second quarter were noteworthy, amounting to $22.1 billion, which represents a 6% increase from the same period last year. This figure indicates a strong pipeline of future work, reflecting the company’s ability to secure new contracts and projects.
The company’s gross margin for the quarter was reported at 30.3%, which is an improvement of 40 basis points from the year-ago quarter. Accenture also maintained a healthy cash position, exiting the quarter with cash and cash equivalents of $9.4 billion. Additionally, the company paid out a dividend of $1 billion during this period, demonstrating its commitment to returning value to shareholders.
Accenture has a history of strong earnings surprises, having surpassed the Zacks Consensus Estimate in three of the last four quarters, with one miss. This trend of exceeding expectations may contribute to investor confidence as the company continues to navigate the complexities of the global market.
Currently, Accenture holds a Zacks Rank of #3 (Hold), indicating a neutral outlook among analysts. Observers will be keen to see how the company addresses the challenges in its health and public service segment and whether it can maintain its growth trajectory in the upcoming quarters. Details remain unconfirmed regarding the long-term impact of these results on Accenture’s strategic direction and market positioning.
